Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:(39):64-8.
doi: 10.1093/jncimonographs/lgn014.

NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men

Affiliations

NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men

Christopher Slape et al. J Natl Cancer Inst Monogr. 2008.

Abstract

The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral blood cytopenias, dysplasia, and a propensity for transformation to acute myeloid leukemia (AML). A wide spectrum of genetic aberrations has been associated with MDS, including chromosomal translocations involving the NUP98 gene, most commonly leading to fusions of NUP98 with abd-b group HOX genes, including HOXD13. We used vav regulatory elements to direct expression of a NUP98-HOXD13 (NHD13) fusion gene in hematopoietic tissues. NHD13 transgenic mice faithfully recapitulate all the key features of MDS, including peripheral blood cytopenias, bone marrow dysplasia and apoptosis, and transformation to acute leukemia. The MDS that develops in NHD13 transgenic mice is highly lethal; within 14 months, 90% of the mice died of either leukemic transformation or severe anemia and leukopenia due to progressive MDS. These mice provide a preclinical model that can be used for the evaluation of MDS therapy and biology.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Ineffective hematopoiesis and dysplasia in NHD13 mice
A and B H &E stained bone marrow from NHD13 (A) and wild-type (B) mice; total cell number from 2 femurs are indicated. Note densely cellular bone marrow in (A) (original magnification × 100). Examples of a dysplastic micromegakaryocyte (C) and multinucleate erythroblast (D) and hypersegmented neutrophil (E) from NHD13 mouse are shown (original magnification × 1000).
Figure 2
Figure 2. Concurrent erythroid and pre-T leukemia in NHD13 mouse 1018
A and B, peripheral blood (A) and bone marrow (B) demonstrating circulating erythroblasts (arrowheads), nucleated red blood cells (arrows), and replacement of bone marrow with erythroblasts (original magnification × 1000). C and D, section of liver infiltrated with leukemic blasts, stained with H&E (C) or anti-CD3 (D) (original magnification × 100). Note lack of CD3 staining in liver. E and F, section of lung infiltrated with leukemic blasts, stained with H&E (E) or anti-CD3 (F). Note strong CD3 staining in lung (original magnification × 100; inset × 400). (G) Southern blot of leukemic tissue hybridized to a TCRB probe. Note germline band in all lanes, and a clonal rearranged band in the Th and Lu (arrow). CD3 staining and presence of Notch1 mutation in infiltrated tissues is indicated as yes (Y) or no (N). Co, non-transgenic control; Th, thymus; Li, liver; Lu, lung; K, kidney; Sp, spleen.

References

    1. Mufti G, List AF, Gore SD, Ho AY. Myelodysplastic syndrome. Hematology (Am Soc Hematol Educ Program) 2003:176–99. - PubMed
    1. Aul C, Germing U, Gattermann N, Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res. 1998;22:93–100. - PubMed
    1. Kurzrock R. Myelodysplastic syndrome overview. Semin Hematol. 2002;39:18–25. - PubMed
    1. Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res. 2003;27:95–120. - PubMed
    1. Slape C, Aplan PD. The role of NUP98 gene fusions in hematologic malignancy. Leuk Lymphoma. 2004;45:1341–50. - PubMed

Publication types